Literature DB >> 22201290

Small-molecule-modified surfaces engage cells through the αvβ3 integrin.

Joseph R Klim1, Anthony J Fowler, Adam H Courtney, Paul J Wrighton, Rachael T C Sheridan, Margaret L Wong, Laura L Kiessling.   

Abstract

Integrins play myriad and vital roles in development and disease. They connect a cell with its surroundings and transmit chemical and mechanical signals across the plasma membrane to the cell's interior. Dissecting their roles in cell behavior is complicated by their overlapping ligand specificity and shared downstream signaling components. In principle, immobilized synthetic peptides can mimic extracellular matrix proteins by supporting integrin-mediated adhesion, but most short peptide sequences lack selectivity for one integrin over others. In contrast, synthetic integrin antagonists can be highly selective. We hypothesized that this selectivity could be exploited if antagonists, when immobilized, could support cellular adhesion and activate signaling by engaging specific cell-surface integrins. To investigate this possibility, we designed a bifunctional (RGD)-based peptidomimetic for surface presentation. Our conjugate combines a high affinity integrin ligand with a biotin moiety; the former engages the α(v)β(3) integrin, and the latter allows for presentation on streptavidin-coated surfaces. Surfaces decorated with this ligand promote both cellular adhesion and integrin activation. Moreover, the selectivity of these surfaces for the α(v)β(3) integrin can be exploited to capture a subset of cells from a mixed population. We anticipate that surfaces displaying highly selective small molecule ligands can reveal the contributions of specific integrin heterodimers to cell adhesion and signaling.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22201290      PMCID: PMC3306508          DOI: 10.1021/cb2004725

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  52 in total

1.  A high-capacity streptavidin-coated microtitration plate.

Authors:  Lasse Välimaa; Kim Pettersson; Markus Vehniäinen; Matti Karp; Timo Lövgren
Journal:  Bioconjug Chem       Date:  2003 Jan-Feb       Impact factor: 4.774

Review 2.  Designing materials for biology and medicine.

Authors:  Robert Langer; David A Tirrell
Journal:  Nature       Date:  2004-04-01       Impact factor: 49.962

Review 3.  Non peptidic alphavbeta3 antagonists: recent developments.

Authors:  Barbara Cacciari; Giampiero Spalluto
Journal:  Curr Med Chem       Date:  2005       Impact factor: 4.530

4.  Cell adhesive PET membranes by surface grafting of RGD peptidomimetics.

Authors:  Stéphane Biltresse; Mireille Attolini; Jacqueline Marchand-Brynaert
Journal:  Biomaterials       Date:  2005-01-18       Impact factor: 12.479

5.  Stem cell separation: a bottleneck in stem cell therapy.

Authors:  Kornelia Schriebl; Shereen Lim; Andre Choo; Anne Tscheliessnig; Alois Jungbauer
Journal:  Biotechnol J       Date:  2010-01       Impact factor: 4.677

6.  Surface coating with cyclic RGD peptides stimulates osteoblast adhesion and proliferation as well as bone formation.

Authors:  M Kantlehner; P Schaffner; D Finsinger; J Meyer; A Jonczyk; B Diefenbach; B Nies; G Hölzemann; S L Goodman; H Kessler
Journal:  Chembiochem       Date:  2000-08-18       Impact factor: 3.164

Review 7.  The design of molecular hosts, guests, and their complexes.

Authors:  D J Cram
Journal:  Science       Date:  1988-05-06       Impact factor: 47.728

Review 8.  Integrin and growth factor receptor crosstalk.

Authors:  B P Eliceiri
Journal:  Circ Res       Date:  2001-12-07       Impact factor: 17.367

9.  Combinatorial chemistry identifies high-affinity peptidomimetics against alpha4beta1 integrin for in vivo tumor imaging.

Authors:  Li Peng; Ruiwu Liu; Jan Marik; Xiaobing Wang; Yoshikazu Takada; Kit S Lam
Journal:  Nat Chem Biol       Date:  2006-06-11       Impact factor: 15.040

10.  alphavbeta3 Integrin-targeting Arg-Gly-Asp (RGD) peptidomimetics containing oligoethylene glycol (OEG) spacers.

Authors:  Vincent Rerat; Georges Dive; Alex A Cordi; Gordon C Tucker; Reine Bareille; Joëlle Amédée; Laurence Bordenave; Jacqueline Marchand-Brynaert
Journal:  J Med Chem       Date:  2009-11-26       Impact factor: 7.446

View more
  8 in total

1.  Integrin-generated forces lead to streptavidin-biotin unbinding in cellular adhesions.

Authors:  Carol Jurchenko; Yuan Chang; Yoshie Narui; Yun Zhang; Khalid S Salaita
Journal:  Biophys J       Date:  2014-04-01       Impact factor: 4.033

2.  Rhamnose glycoconjugates for the recruitment of endogenous anti-carbohydrate antibodies to tumor cells.

Authors:  Rachael T C Sheridan; Jonathan Hudon; Jacquelyn A Hank; Paul M Sondel; Laura L Kiessling
Journal:  Chembiochem       Date:  2014-06-06       Impact factor: 3.164

3.  Signals from the surface modulate differentiation of human pluripotent stem cells through glycosaminoglycans and integrins.

Authors:  Paul J Wrighton; Joseph R Klim; Brandon A Hernandez; Chad H Koonce; Timothy J Kamp; Laura L Kiessling
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-24       Impact factor: 11.205

Review 4.  Defining synthetic surfaces for human pluripotent stem cell culture.

Authors:  Jack W Lambshead; Laurence Meagher; Carmel O'Brien; Andrew L Laslett
Journal:  Cell Regen (Lond)       Date:  2013-11-22

5.  Synthesis and Evaluation of a Non-Peptide Small-Molecule Drug Conjugate Targeting Integrin αVβ3.

Authors:  Jannik Paulus; Norbert Sewald
Journal:  Front Chem       Date:  2022-04-11       Impact factor: 5.545

6.  MUC1* ligand, NM23-H1, is a novel growth factor that maintains human stem cells in a more naïve state.

Authors:  Benoit J Smagghe; Andrew K Stewart; Mark G Carter; Laura M Shelton; Kyle J Bernier; Eric J Hartman; Amy K Calhoun; Vasilios M Hatziioannou; Gabriele Lillacci; Brian A Kirk; Brian A DiNardo; Kenneth S Kosik; Cynthia Bamdad
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

7.  Long-Term Maintenance of Human Pluripotent Stem Cells on cRGDfK-Presenting Synthetic Surfaces.

Authors:  Jack W Lambshead; Laurence Meagher; Jacob Goodwin; Tanya Labonne; Elizabeth Ng; Andrew Elefanty; Edouard Stanley; Carmel M O'Brien; Andrew L Laslett
Journal:  Sci Rep       Date:  2018-01-15       Impact factor: 4.379

8.  Combining Biologically Active β-Lactams Integrin Agonists with Poly(l-lactic acid) Nanofibers: Enhancement of Human Mesenchymal Stem Cell Adhesion.

Authors:  Giulia Martelli; Nora Bloise; Andrea Merlettini; Giovanna Bruni; Livia Visai; Maria Letizia Focarete; Daria Giacomini
Journal:  Biomacromolecules       Date:  2020-02-14       Impact factor: 6.988

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.